UDG Healthcare logo

UDG - UDG Healthcare Share Price

767.5p 28.5  3.9%

Last Trade - 25/09/20

Sector
Healthcare
Size
Mid Cap
Market Cap £1.93bn
Enterprise Value £2.07bn
Revenue £1.05bn
Position in Universe 270th / 1808
Bullish
Bearish
Unlock UDG Revenue
Momentum
Relative Strength (%)
1m +10.5%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -9.28%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Sep 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
1,037 1,053 1,083 1,220 1,315 1,299 1,286 1,366 +4.6%
-43.4 +16.6 +20.4 +6.6 +25.9 +10.8 +7.42 +16.0
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 31 March 2020, Udg Healthcare PLC revenues increased 6% to $693.6M. Net income before extraordinary items increased from $23M to $55.3M. Revenues reflect Sharp segment increase of 12% to $185.8M, Ashfield segment increase of 3% to $507.8M, North america segment increase of 10% to $454.6M. Net income benefited from Unallocated segment income totaling $5.3M vs. loss of $15.2M, Ashfield segment income increase of 24% to $58.6M.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for UDG
Graphical History

Revenue

UDG Revenue Unlock UDG Revenue

Net Income

UDG Net Income Unlock UDG Revenue

Normalised EPS

UDG Normalised EPS Unlock UDG Revenue

PE Ratio Range

UDG PE Ratio Range Unlock UDG Revenue

Dividend Yield Range

UDG Dividend Yield Range Unlock UDG Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
UDG EPS Forecasts Unlock UDG Revenue
Profile Summary

UDG Healthcare PLC is an Ireland-based company that provides advisory, commercial, clinical, communications and packaging services to the healthcare industry with operations in approximately 25 countries and delivering services in over 50 countries. The Company operates across two divisions: Ashfield and Sharp. Ashfield provides advisory, communication, commercial and clinical services for the pharmaceutical and healthcare industries and provides field and contact center sales teams, healthcare communications, patient support, audit, advisory, medical information and event management services to healthcare companies. Sharp provides contract commercial packaging and clinical trial packaging services for the pharmaceutical and healthcare industries. Sharp operates facilities in the United States and Europe.

Directors
Last Annual September 30th, 2019
Last Interim March 31st, 2020
Incorporated January 19, 1948
Public Since March 5, 1992
No. of Shareholders: n/a
No. of Employees: 9,000
Sector Healthcare
Industry Healthcare Providers & Services
Index FTSE All Share , FTSE All Share Health Care , FTSE All Share Health Care Equipment & Services , FTSE 350 , FTSE 350 Lower Yield , FTSE 250 , FTSE 350 Health Care Equipment & Services ,
Exchange London Stock Exchange (Full)
Shares in Issue 251,056,334
Free Float (0.0%)
Eligible for
ISAs
SIPPs
UDG Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for UDG
Upcoming Events for UDG
Tuesday 24th November, 2020
Full Year 2020 UDG Healthcare plc Earnings Release
Frequently Asked Questions for UDG Healthcare
What is the UDG Healthcare share price?

As of 25/09/20, shares in UDG Healthcare are trading at 767.5p, giving the company a market capitalisation of £1.93bn. This share price information is delayed by 15 minutes.

How has the UDG Healthcare share price performed this year?

Shares in UDG Healthcare are currently trading at 767.5p and the price has moved by 2.47% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the UDG Healthcare price has moved by 28.56% over the past year.

What are the analyst and broker recommendations for UDG Healthcare?

Of the analysts with advisory recommendations for UDG Healthcare, there are there are currently 4 "buy" , 3 "hold" and 0 "sell" recommendations. The overall consensus recommendation for UDG Healthcare is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will UDG Healthcare next release its financial results?

UDG Healthcare is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-03-31
What is the UDG Healthcare dividend yield?

The UDG Healthcare dividend yield is 1.26% based on the trailing twelve month period.

Does UDG Healthcare pay a dividend?

Last year, UDG Healthcare paid a total dividend of 0.12, and it currently has a trailing dividend yield of 1.26%. Looking ahead, UDG Healthcare has not announced an ex-dividend date yet.

When does UDG Healthcare next pay dividends?

UDG Healthcare has yet to annouce their ex-dividend date. The historic dividend yield on UDG Healthcare shares is currently 1.26%.

How do I buy UDG Healthcare shares?

To buy shares in UDG Healthcare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of UDG Healthcare?

Shares in UDG Healthcare are currently trading at 767.5p, giving the company a market capitalisation of £1.93bn.

Where are UDG Healthcare shares listed? Where are UDG Healthcare shares listed?

Here are the trading details for UDG Healthcare:

Country of listing: United Kingdom
Exchange: LSE
Ticker Symbol: UDG
What kind of share is UDG Healthcare?

Based on an overall assessment of its quality, value and momentum, UDG Healthcare is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a UDG Healthcare share price forecast 2020?

Shares in UDG Healthcare are currently priced at 767.5p. At that level they are trading at 7.96% discount to the analyst consensus target price of 833.88.

Analysts covering UDG Healthcare currently have a consensus Earnings Per Share (EPS) forecast of 0.451 for the next financial year.

How can I tell whether the UDG Healthcare share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like UDG Healthcare. Over the past six months, the relative strength of its shares against the market has been 20.68%. At the current price of 767.5p, shares in UDG Healthcare are trading at 7.99% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the UDG Healthcare PE Ratio?

The UDG Healthcare PE ratio based on its reported earnings over the past 12 months is 20.18. The shares are currently trading at 767.5p.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of UDG Healthcare?

UDG Healthcare's management team is headed by:

Peter Gray - NEC
Brendan McAtamney - CEO
Damien Moynagh - GCN
Myles Lee - NID
Nigel Clerkin - CFO
Peter Chambre - NID
Shane Cooke - NEC
Eleanor Garvey - OTH
Eimear Kenny - OTH
Liam Logue - EVP
Mike O'Hara - MDR
Julian Tompkins - CEX
Doug Burcin - CEX
Rob Wood - CEX
Liz Shanahan - NED
Who are the major shareholders of UDG Healthcare?

Here are the top five shareholders of UDG Healthcare based on the size of their shareholding:

Allianz Global Investors GmbH Investment Advisor
Percentage owned: 8.93% (22.4m shares)
Kabouter Management, L.L.C. Hedge Fund
Percentage owned: 5.06% (12.7m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 4.35% (10.9m shares)
The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 3.87% (9.73m shares)
Fidelity Management & Research Company LLC Investment Advisor
Percentage owned: 3.21% (8.06m shares)
Similar to UDG
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.